Vivo Ventures Fund VII, L.P.

CIK 1509160 · last filed 2022-07-01

Vivo Ventures Fund VII, L.P. is a corporate insider who has filed 7 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing shows the insider disposed of $1.28B of SRRA on Jul 1, 2022. Across all open-market trades the lifetime net is +$8.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $22.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$22.04M

Companies

4

Total Filings

7

Lifetime Open-Market Net

$8.29M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Sierra Oncology, Inc. (SRRA) Delisted	Director	0	$54.99	$0	$0	3	2022-07-01
CDXS	10%+ Owner	118,240	$1.50	$177.4K	-$1.01M	1	2016-08-05
ACRS	10%+ Owner	4,101,997	$5.33	$21.86M	$15.00M	1	2015-10-13
Lite Strategy, Inc. (MEIP) Delisted	10%+ Owner	198,988	$3.20	$636.8K	-$5.70M	2	2013-07-02

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-07-01	Sierra Oncology, Inc. (SRRA) Delisted	Disp (D)	−23,306,584	-$1.28B	EDGAR
2022-01-28	Sierra Oncology, Inc. (SRRA) Delisted	Exer (X)	+4,287,059	$56.59M	EDGAR
2020-01-31	Sierra Oncology, Inc. (SRRA) Delisted	Conv (C)	+12,992,826	$0	EDGAR
2016-08-05	CDXS	Sell (S)	−240,000	-$1.01M	EDGAR
2015-10-13	ACRS	Mixed	+11,664,573	$15.00M	EDGAR
2013-07-02	Lite Strategy, Inc. (MEIP) Delisted	Sell (S)	−22,011	-$166.8K	EDGAR
2013-06-13	Lite Strategy, Inc. (MEIP) Delisted	Sell (S)	−708,819	-$5.53M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.